KURA · Kura Oncology, Inc. · Documents
$9.99
+0.63 (+6.73%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$832.67M
Shares
88.96M
Volume · Oct 20
1.54M
Avg daily vol (3M)
1.84M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| Investor Event Transcript | Kura Oncology retains approximately 50 percent ownership of Caspian Therapeutics after a $50 million financing supporting KO7246’s IND-enabling development; initial clinical work targets healthy volunteers next year, with data anticipated in late 28 or possibly early 29. | 2026-10-13 | 2026-12-31 | |
| Investor Event Transcript | — | 2026-09-16 | 2026-09-30 | |
| 8-K | — | 2026-09-09 | — | |
| 8-K | — | 2026-09-08 | — | |
| 8-K | — | 2026-08-12 | — | |
| 10-Q | — | 2026-08-12 | 2026-06-30 | |
| 8-K | — | 2026-07-29 | 2026-07-24 | |
| Investor Event Transcript | — | 2026-07-27 | 2026-09-30 | |
| 8-K | — | 2026-06-04 | — | |
| DEFA14A | — | 2026-05-26 | — | |
| 8-K | — | 2026-05-12 | — | |
| 10-Q | — | 2026-05-12 | 2026-03-31 | |
| Investor Event Transcript | — | 2026-04-17 | 2026-06-30 | |
| DEFA14A | — | 2026-04-10 | — | |
| ARS | — | 2026-04-10 | 2025-12-31 | |
| DEF 14A | — | 2026-04-10 | 2026-06-04 | |
| 8-K | — | 2026-03-05 | — | |
| 10-K | — | 2026-03-05 | 2025-12-31 | |
| 8-K | — | 2026-01-29 | 2026-01-28 | |
| 8-K | — | 2026-01-12 | 2026-01-11 | |
| 8-K | — | 2025-12-02 | — | |
| 8-K | — | 2025-11-13 | — | |
| 10-Q | — | 2025-11-04 | 2025-09-30 | |
| 8-K | — | 2025-11-04 | — | |
| 8-K | — | 2025-10-24 | — | |
| 8-K | — | 2025-10-16 | 2025-10-15 | |
| 10-Q | — | 2025-08-07 | 2025-06-30 | |
| 8-K | — | 2025-08-07 | — | |
| 8-K | — | 2025-07-01 | 2025-06-27 | |
| 8-K | — | 2025-06-18 | 2025-06-12 | |
| 8-K | — | 2025-06-06 | 2025-06-05 | |
| 8-K | — | 2025-06-03 | 2025-06-01 | |
| 8-K | — | 2025-05-01 | — | |
| 10-Q | — | 2025-05-01 | 2025-03-31 | |
| ARS | — | 2025-04-17 | 2024-12-31 | |
| DEFA14A | — | 2025-04-11 | — | |
| DEF 14A | — | 2025-04-11 | 2025-06-05 | |
| 10-K | — | 2025-02-28 | 2024-12-31 | |
| 8-K | — | 2025-02-26 | — | |
| 8-K | — | 2025-02-05 | — | |
| 8-K | — | 2025-01-14 | 2025-01-13 | |
| 8-K | — | 2025-01-06 | 2025-01-01 | |
| 8-K | — | 2024-12-20 | 2024-12-16 | |
| 8-K | — | 2024-11-20 | — | |
| 8-K | — | 2024-11-07 | — | |
| 10-Q | — | 2024-11-07 | 2024-09-30 | |
| 8-K | — | 2024-09-17 | 2024-09-13 | |
| 8-K | — | 2024-08-08 | — | |
| 10-Q | — | 2024-08-08 | 2024-06-30 | |
| 8-K | — | 2024-06-07 | 2024-06-05 |
Showing 1–50 of 144 filings
Key facts
CIK
1422143
CUSIP
50127T109
13F (30d)
22 filings
22 filers
Visit website
Investor relations